Leerink Partnrs Weighs in on KPTI Q1 Earnings
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Free Report) – Equities research analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Karyopharm Therapeutics in a report issued on Wednesday, February 19th. Leerink Partnrs analyst J. Chang expects that the company will post earnings per share of ($0.26) for the quarter. The consensus estimate […]
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Free Report) – Equities research analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Karyopharm Therapeutics in a report issued on Wednesday, February 19th. Leerink Partnrs analyst J. Chang expects that the company will post earnings per share of ($0.26) for the quarter. The consensus estimate […]
